Skip to main content
Clinical Trials/ACTRN12622000249752
ACTRN12622000249752Not yet recruiting未知

A randomised, controlled trial of the efficacy and safety of Eye Movement Desensitisation and Reprocessing via telehealth compared with in person in Australian veterans with Posttraumatic Stress Disorder

Concord Repatriation General Hospital0 sites60 target enrollmentStarted: February 11, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • 1. Australian veterans attending the National Centre for Veterans' Healthcare (NCVH)
  • 2. Department of Veterans’ Affairs (DVA) accepted clinical diagnosis of PTSD, which have been confirmed by NCVH clinicians administering and trained in the Structured Clinical Interview for DSM 5 (SCID-5)
  • 3. Suitable for treatment with EMDR

Exclusion Criteria

  • 1.No prior treatment with EMDR
  • 2.No history of acquired brain injury from any cause, which may increase the risk of developing PTSD but the impact of acquired brain injury on treatment for PTSD with EMDR is currently unknown
  • 3.No active alcohol, benzodiazepine, or illicit substance use, which are common comorbidities among patients with PTSD but are generally considered relative contraindications for EMDR on the basis of their effects on long term potentiation

Investigators

Similar Trials